This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Frailty Detection, Assessment and Prediction (62) Cancer and Clinical Trials (41) Chemotherapy and Side Effects Management (110) Doctor-Patient Communication on Cancer, Prevention, and Screening (78) Patient-Reported Outcome Measures (PROMs) (372)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/76628, first published .
Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Authors of this article:

Ruofei Du1 Author Orcid Image ;   Ying Zhang2 Author Orcid Image ;   Huimin Yang1, 2 Author Orcid Image ;   Yating Du2 Author Orcid Image ;   Jin Li1 Author Orcid Image ;   Bingyan Zhang3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

There are no citations yet available for this article according to Crossref .